Genome-wide patterns of recombination in the opportunistic human pathogen pseudomonas aeruginosa

Genome Biology and Evolution

Volumn 7, Issue 1, 2014, Pages 18-34

  Dettman, Jeremy R ^a   Rodrigue, Nicolas ^b   Kassen, Rees ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CARLETON UNIVERSITY   (Canada)

Author keywords

adaptation; comparative genomics; epidemic; Homologous recombination; horizontal transfer; population genomics

Indexed keywords

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

BACTERIAL GENOME; GENETIC RECOMBINATION; GENETICS; GENOMICS; HUMAN; MICROBIOLOGY; MUTATION; OPPORTUNISTIC INFECTION; PATHOGENICITY; PATHOLOGY; PHYLOGENY; PSEUDOMONAS AERUGINOSA;

GENOME, BACTERIAL; GENOMICS; HUMANS; MUTATION; OPPORTUNISTIC INFECTIONS; PHYLOGENY; PSEUDOMONAS AERUGINOSA; RECOMBINATION, GENETIC;

EID: 84928231169     PISSN: None     EISSN: 17596653     Source Type: Journal    
DOI: 10.1093/gbe/evu260     Document Type: Article

References (61)

1. Aaron SD, et al. 2010. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis. JAMA 304:2145-2153.
2. Al-Aloul M, et al. 2004. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax 59:334-336.
3. Armstrong DS, et al. 2002. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care. 166:983-987.
4. Atichartpongkul S, Fuangthong M, Vattanaviboon P, Mongkolsuk S. 2010. Analyses of the regulatory mechanism and physiological roles of Pseudomonas aeruginosa OhrR, a transcription regulator and a sensor of organic hydroperoxides. J Bacteriol. 192:2093-2101.
5. Awadalla P. 2003. The evolutionary genomics of pathogen recombination. Nat Rev Genet. 4:50-60.
6. Bakkal S, Robinson SM, Ordonez CL, Waltz DA, Riley MA. 2010. Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients. Microbiology 156:2058-2067.
7. Beaudoin T, Aaron SD, Giesbrecht-Lewis T, Vandemheen K, Mah TF. 2010. Characterization of clonal strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Ontario, Canada. Can J Microbiol 56: 548-557.
8. Benson TE, Filman DJ, Walsh CT, Hogle JM. 1995. An enzyme-substrate complex involved in bacterial-cell wall biosynthesis. Nat Struct Biol. 2: 644-653.
9. Bleves S, et al. 2010. Protein secretion systems in Pseudomonas aeruginosa: a wealth of pathogenic weapons. Int J Med Microbiol. 300: 534-543.
10. Carter MQ, Chen JS, Lory S. 2010. The Pseudomonas aeruginosa pathogenicity island PAPI-1 Is transferred via a novel type IV pilus. J Bacteriol. 192:3249-3258.
11. Cramer N, et al. 2011. Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs. Environ Microbiol. 13:1690-1704.
12. Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. 2004. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol. 42:5644-5649.
13. Darling AE, Mau B, Perna NT. 2010. progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One 5: e11147.
14. Dettman JR, Rodrigue N, Aaron SD, Kassen R. 2013. Evolutionary genomics of epidemic and nonepidemic strains of Pseudomonas aeruginosa. Proc Natl Acad Sci USA. 110:21065-21070.
15. Didelot X, Darling A, Falush D. 2009. Inferring genomic flux in bacteria. Genome Res. 19:306-317.
16. Didelot X, et al. 2011. Recombination and population structure in Salmonella enterica. PLoS Genet. 7:e1002191.
17. Didelot X, Falush D. 2007. Inference of bacterial microevolution using multilocus sequence data. Genetics 175:1251-1266.
18. Didelot X, Maiden MCJ. 2010. Impact of recombination on bacterial evolution. Trends Microbiol. 18:315-322.
19. Dotsch A, et al. 2009. Genomewide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 53:2522-2531.
20. Enright MC, et al. 2002. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA. 99: 7687-7692.
21. Falush D, Stephens M, Pritchard JK. 2003. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164:1567-1587.
22. Gotz S, et al. 2008. High-throughput functional annotation and data mining with the Blast2GO suite. Nucleic Acids Res. 36:3420-3435.
23. Guindon S, et al. 2010. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol. 59:307-321.
24. Hahn HP. 1997. The type-4 pilus is the major virulence-associated adhesin of Pseudomonas aeruginosa-A review. Gene 192:99-108.
25. Hancock REW, et al. 1983. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side-chain. Infect Immun. 42:170-177.
26. Hauser AR, JainM, Bar-MeirM, McColley SA. 2011. Clinical significance of microbial infection and adaptation in cystic fibrosis. ClinMicrobiol Rev. 24:29-70.
27. Hauser PM, et al. 2014. Microbiota present in cystic fibrosis lungs as revealed by whole genome sequencing. PLoS One 9:e90934.
28. He M, et al. 2010. Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci USA. 107:7527-7532.
29. Hood RD, et al. 2010. A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. Cell Host Microbe 7:25-37.
30. Huson DH, Bryant D. 2006. Application of phylogenetic networks in evolutionary studies. Mol Biol Evol. 23:254-267.
31. Jackson RW, Vinatzer B, Arnold DL, Dorus S, Murillo J. 2011. The influence of the accessory genome on bacterial pathogen evolution. Mob Genet Elements. 1:55-65.
32. Jeukens J, et al. 2014. Comparative genomics of isolates of a Pseudomonas aeruginosa epidemic strain associated with chronic lung infections of cystic fibrosis patients. PLoS One 9:e87611.
33. Joseph SJ, et al. 2012. Population genomics of Chlamydia trachomatis: insights on drift, selection, recombination, and population structure. Mol Biol Evol. 29:3933-3946.
34. Kida Y, Shimizu T, Kuwano K. 2011. Cooperation between LepA and PlcH contributes to the in vivo virulence and growth of Pseudomonas aeruginosa in Mice. Infect Immun. 79:211-219.
35. Kida Y, Taira J, Yamamoto T, Higashimoto Y, Kuwano K. 2013. EprS, an autotransporter protein of Pseudomonas aeruginosa, possessing serine protease activity induces inflammatory responses through protease-activated receptors. Cell Microbiol. 15:1168-1181.
36. Kidd TJ, et al. 2012. Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting. PLoS One 7:e44199.
37. Kiewitz C, Tummler B. 2000. Sequence diversity of Pseudomonas aeruginosa: impact on population structure and genome evolution. J Bacteriol. 182:3125-3135.
38. Kocincova D, Ostler SL, Anderson EM, Lam JS. 2012. Rhamnosyltransferase genes migA and wapR are regulated in a differential manner to modulate the quantities of core oligosaccharide glycoforms produced by Pseudomonas aeruginosa. J Bacteriol. 194: 4295-4300.
39. Kung VL, Ozer EA, Hauser AR. 2010. The Accessory genome of Pseudomonas aeruginosa. Microbiol Mol Biol Rev. 74:621-641.
40. Langaee TY, DargisM, Huletsky A. 1998. An ampD gene in Pseudomonas aeruginosa encodes a negative regulator of AmpC beta-lactamase expression. Antimicrob Agents Chemother. 42:3296-3300.
41. Langille MGI, Brinkman FSL. 2009. IslandViewer: an integrated interface for computational identification and visualization of genomic islands. Bioinformatics 25:664-665.
42. Librado P, Rozas J. 2009. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 25:1451-1452.
43. LiPuma JJ. 2010. The Changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev. 23:299-323.
44. Maatallah M, et al. 2011. Population structure of Pseudomonas aeruginosa from fiveMediterranean countries: evidence for frequent recombination and epidemic occurrence of CC235. PLoS One 6:e25617.
45. Marttinen P, et al. 2012. Detection of recombination events in bacterial genomes from large population samples. Nucleic Acids Res. 40:e6.
46. Mima T, Sekiya H, Mizushima T, Kuroda T, Tsuchiya T. 2005. Gene cloning and properties of the RND-type multidrug efflux pumps mexPQ-opmE and mexMN-oprM from Pseudomonas aeruginosa. Microbiol Immunol. 49:999-1002.
47. Mougous JD, et al. 2006. A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. Science 312:1526-1530.
48. Namouchi A, Didelot X, Schock U, Gicquel B, Rocha EPC. 2012. After the bottleneck: genome-wide diversification of the Mycobacterium tuberculosis complex by mutation, recombination, and natural selection. Genome Res. 22:721-734.
49. Palmer KL, Aye LA, Whiteley M. 2007. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol. 189:8079-8087.
50. Pirnay JP, et al. 2009. Pseudomonas aeruginosa population structure revisited. PLoS One 4:e7740.
51. Potvin E, et al. 2003. In vivo functional genomics of Pseudomonas aeruginosa for high-throughput screening of new virulence factors and antibacterial targets. Environ Microbiol. 5:1294-1308.
52. Regunathan S, Piletz JE. 2003. Regulation of inducible nitric oxide synthase and agmatine synthesis in macrophages and astrocytes. Ann N Y Acad Sci. 1009:20-29.
53. Rocchetta HL, Burrows LL, Lam JS. 1999. Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa. Microbiol Mol Biol Rev. 63: 523-553.
54. Schoustra SE, Dench J, Dali R, Aaron SD, Kassen R. 2012. Antagonistic interactions peak at intermediate genetic distance in clinical and laboratory strains of Pseudomonas aeruginosa. BMC Microbiol. 12:40.
55. Segerman B. 2012. The genetic integrity of bacterial species: the core genome and the accessory genome, two different stories. Front Cell Infect Microbiol. 2:116.
56. Smith EE, et al. 2006. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA. 103: 8487-8492.
57. Snitkin ES, et al. 2011. Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii. Proc Natl Acad Sci USA. 108:13758-13763.
58. Spencer DH, et al. 2003. Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J Bacteriol. 185: 1316-1325.
59. Wilhelm S, Gdynia A, Tielen P, Rosenau F, Jaeger KE. 2007. The autotransporter esterase EstA of Pseudomonas aeruginosa is required for rhamnolipid production, cell motility, and biofilm formation. J Bacteriol. 189:6695-6703.
60. Winstanley C, et al. 2009. Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Res. 19:12-23.
61. Yang L, et al. 2011. Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci USA. 108:7481-7486.